Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area metabolism pde'

Search results for: 'research area metabolism pde'

Items 11-20 of 62

Page
per page
  1. Ciprofibrate
    A4306 Ciprofibrate
    Summary: PPARα agonist
      insoluble in H2O; ≥10.85 mg/mL
  2. GW501516
    A4309 GW501516
     1 Citation
    Summary: PPARδ agonist,selective and potent
      insoluble in H2O; ≥18.05 mg/mL
  3. Avasimibe
    A4318 Avasimibe
    Target: Acyl coenzyme A: cholesterol acyltransferases
    Summary: ACAT inhibitor,orally bioavailable
      ≥25.09 mg/mL
  4. Clarithromycin
    A4322 Clarithromycin
    Target: Cytochrome P450 (CYP450)
    Summary: CYP3A inhibitor, potent
      ≥31.2 mg/mL
  5. Pioglitazone HCl
    A4324 Pioglitazone HCl
    Summary: PPARγ agonist
      insoluble in H2O; ≥19.65 mg/mL
  6. PF-2545920
    A4325 PF-2545920
    Target: Phosphodiesterases (PDEs)
    Summary: PDE10A inhibitor,potent and selective
      insoluble in H2O; ≥19.35 mg/mL
  7. Isotretinoin
    A4330 Isotretinoin
    Target: RARs
    Summary: Dopamine β-hydroxylase activator
      insoluble in H2O; ≥13.8 mg/mL
  8. Avanafil
    A4334 Avanafil
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL
  9. Mildronate
    A4335 Mildronate
    Target: Hydroxylases|carnitine reabsorption
    Summary: GBB hydroxylase inhibitor
  10. Cilostazol
    A4337 Cilostazol
    Summary: PDE3 inhibitor
      insoluble in H2O; ≥15.4 mg/mL

Items 11-20 of 62

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 61item
Specificity
  1. Selective 45item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 13item
  4. RARs 1 item
  5. Estrogen and Related Receptors 1 item
  6. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  7. AMPK 1 item
  8. Cytochrome P450 (CYP450) 4item
  9. HMG-CoA Reductases 3item
  10. SGLT 1 item
  11. DGAT 2item
  12. Insulin and Insulin-like Receptors 1 item
  13. Pyruvate dehydrogenases (PDH) 1 item
  14. CETP 2item
  15. Fatty-acid-binding proteins (FABPs) 1 item
  16. Folate Analogue 1 item
  17. Nampt 1 item
  18. Carbonic Anhydrases 3item
  19. Histamine H1 Receptors 1 item
  20. Phospholipases 1 item
  21. Catechol O-Methyltransferase (COMT) 1 item
  22. Hydroxylases 1 item
  23. ATGL 1 item
  24. FPTase 1 item
  25. PPAR 1 item
  26. FAAH 1 item
  27. carnitine reabsorption 1 item
  28. TRPC channel 1 item
Related Disease
  1. Acne 1 item
  2. Acute Kidney Injury 1 item
  3. Bladder Cancer 1 item
  4. Bladder Carcinoma 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 5item
  7. Cancer 14item
  8. Cervical Cancer 1 item
  9. Cocaine-Related Disorders 1 item
  10. Diabetes 1 item
  11. Dyslipidemia 2item
  12. Erectile Dysfunction 3item
  13. HIV 1 item
  14. Hypercholesterolemia 2item
  15. Inflammation 1 item
  16. Inflammatory Diseases 2item
  17. Kidney Injury Studies 1 item
  18. Leukemia 2item
  19. Lung Cancer 2item
  20. Lymphoma 3item
  21. Melanoma 2item
  22. Neuroblastoma 3item
  23. Neurocognitive Disorders 1 item
  24. Obsessive-Compulsive Disorder 1 item
  25. Prostate Cancer 2item
  26. Psoriasis 2item
  27. Psoriasis Vulgaris 1 item
  28. Pulmonary Arterial Hypertension 1 item
  29. Rheumatoid Arthritis 2item
  30. Schizophrenia 2item
  31. Type 2 Diabetes 4item